Mark Ledwidge
Overview
Explore the profile of Mark Ledwidge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Counihan M, Stein I, Flynn C, ORegan A, Clarke S, Ledwidge M, et al.
Res Social Adm Pharm
. 2025 Feb;
21(5):287-320.
PMID: 39952840
Background: The scope of practice for community pharmacists across the United Kingdom (UK) and Ireland is expanding, with advanced pharmacy services (APS) that exceed the traditional scope of practice of...
2.
Demirdjian S, Kerr M, Mulhern M, Thompson P, Ledwidge M, McCann M
J Nutr
. 2025 Feb;
155(3):1005.
PMID: 39892878
No abstract available.
3.
Demirdjian S, Kerr M, Mulhern M, Thompson P, Ledwidge M, McCann M
J Nutr
. 2024 Sep;
154(10):3048-3059.
PMID: 39236809
Background: Overweight/obesity and iron deficiency (ID) are highly prevalent in women of reproductive age (WRA), impacting on women's health. Obesity is a risk factor for nutritional deficiencies but its association...
4.
Kerrigan L, Edgar K, Russell-Hallinan A, Cappa O, Glezeva N, Galan-Arriola C, et al.
ESC Heart Fail
. 2024 Sep;
12(1):150-165.
PMID: 39233619
Aims: Dynamic alterations in cardiac DNA methylation have been implicated in the development of heart failure (HF) with evidence of ischaemic heart disease (IHD); however, there is limited research into...
5.
Tonry C, Linden K, Collier P, Ledwidge M, McDonald K, Collins B, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200175
Hypertrophic cardiomyopathy (HCM) is a disease, which is difficult to diagnose at an early stage and for which there is a pressing need for more effective treatment options. The purpose...
6.
Wong B, Ryan C, Fagbamigbe A, Bray J, McNamee B, Niranjan V, et al.
Cochrane Database Syst Rev
. 2024 Aug;
8:CD015398.
PMID: 39119865
This is a protocol for a Cochrane Review (prototype). The objectives are as follows: Main objective To assess the effects of alcohol consumption on the progression to symptomatic (stage C)...
7.
Davy K, Koskinas E, Watson C, Ledwidge M, Mbakaya B, Chisale M, et al.
J Trop Pediatr
. 2024 Jul;
70(4).
PMID: 39025514
Objective: To identify the prevalence of respiratory syncytial virus (RSV) in a cohort of children under 5 years of age with World Health Organization (WHO)-defined pneumonia and the factors associated...
8.
Russell-Hallinan A, Cappa O, Kerrigan L, Tonry C, Edgar K, Glezeva N, et al.
Cells
. 2024 May;
13(9.
PMID: 38727290
Dilated cardiomyopathy (DCM) is the most common cause of heart failure, with a complex aetiology involving multiple cell types. We aimed to detect cell-specific transcriptomic alterations in DCM through analysis...
9.
Wong B, Moore A, McDonald K, Ledwidge M
J Card Fail
. 2024 Apr;
30(12):1555-1563.
PMID: 38679412
Background: This study aimed to understand the dose-response relationship between alcohol consumption, progression of left ventricular dysfunction (LVD) and/or symptomatic heart failure (HF) in an older European population at risk...
10.
McErlean S, Broughan J, McCombe G, Fawsitt R, Ledwidge M, Cullen W, et al.
Fam Pract
. 2024 Jan;
41(5):817-824.
PMID: 38289586
Background: Worldwide, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults and poses a significant burden to patients, physicians, and healthcare systems. We developed a quality of...